Why is Eiko Lifescience falling/rising?

As of 04-Jul, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 62.46, which reflects a decrease of Rs 2.34 or 3.61%. Today's performance indicates that the stock has underperformed its sector by 3.74% and has fallen after two consecutive days of gains, reaching an intraday low of Rs 59.42, a drop of 8.3%. Despite this decline, the stock has shown strong performance over the past year with a return of 22.04%, significantly outperforming the broader market's return of 2.13%. Additionally, the promoters have increased their stake by 4.96%, indicating confidence in the company's future, although the stock's long-term fundamental strength is questioned due to a low average Return on Equity (ROE) of 2.82% and a high Price to Book Value ratio.
In the broader market context, Eiko Lifesciences' recent short-term performance contrasts with the benchmark, as it has gained 23.10% over the past week while the Sensex has decreased by 0.74%. However, the stock's year-to-date performance shows a slight decline of 0.45%, while the Sensex has increased by 6.77%. This suggests that while the stock has had periods of strong performance, it is currently facing challenges that may be affecting investor sentiment, particularly in light of its weak long-term fundamentals and recent flat sales results.